Placebo + Nicotine
Phase 3Terminated 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Mar 1, 2011 → Jun 1, 2011
NCT ID
NCT01296698About Placebo + Nicotine
Placebo + Nicotine is a phase 3 stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is terminated. This product is registered under clinical trial identifier NCT01296698. Target conditions include Tobacco Dependence.
What happened to similar drugs?
7 of 9 similar drugs in Tobacco Dependence were approved
Approved (7) Terminated (2) Active (2)
Hype Score Breakdown
Clinical
17
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01296698 | Phase 3 | Terminated |
Competing Products
20 competing products in Tobacco Dependence